April 21, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreApril 21, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreMarch 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreApril 27, 2026
U.S. Bispecific Antibody Market (By Therapeutic Area/Indication: Oncology, Immuno-inflammation/Autoimmunity, Infectious Diseases, Ophthalmology/Rare Diseases/Others; By Format/Architecture: Dual-variable/IgG-based bispecifics, T-cell Engagers, Bispecific Fc-fusion/Fc-silent multispecifics, Trispecific/multispecific/conjugated bispecifics, Bispecifi...
April 27, 2026
microRNA Market (By Products & Services: Services, Products; By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Others; By End-use: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Others; By Region: North America, Asia Pacific, Europe, L...
April 24, 2026
Fragment Analysis Market (By Product & Service: Instruments, Reagents & Consumables, Services; By Technology: Capillary Electrophoresis, Polymerase Chain Reaction, DNA Sequencing, Others; By Application: Genotyping & Polymorphism Analysis, Molecular Diagnostics, Forensic & Paternity Testing, Agricultural & Animal Genomics, Other...
April 21, 2026
The next-generation metabolic therapies market is witnessing strong expansion and is expected to generate revenue in the hundreds of millions during the forecast period from 2026 to 2035, driven by rising cases of metabolic disorders such as obesity, diabetes, NAFLD/NASH, and cardiometabolic syndrome....
April 21, 2026
According to market projections, the rotavirus vaccines market was valued at USD 5.25 billion in 2025 and is projected to grow from USD 5.78 billion in 2026 to USD 13.79 billion by 2035, registering a CAGR of 10.14% during the forecast period. The report covers detailed segment-wise data by vaccine type, route of administration, immunization progra...
April 21, 2026
Market insights predict the recombinant albumin market was valued at USD 152.9 million in 2025 and is projected to grow from USD 162.2 million in 2026 to USD 275.89 million by 2035, registering a CAGR of 6.08% during the forecast period. The report provides detailed insights into market size, growth trends, dosage form segments, application segment...
April 21, 2026
According to market projections, the global endonucleases market, valued at USD 394.3 million in 2025, is anticipated to reach USD 963.86 million by 2035, growing at a CAGR of 9.35% over the next decade.The endonucleases market is increasing rapidly, as these enzymes are contributing to recognizing and cutting up foreign DNA incoming the cell; thei...
April 21, 2026
The quantum flex cell expansion system market is projected to generate hundreds of millions in revenue between 2026 and 2035, driven by rising investments in cell and gene therapy manufacturing, automation, and closed-system processing. The report provides market size estimates, growth forecasts, and detailed segmentation data by system component, ...
April 21, 2026
The cell therapy solvent suspension tubing market is driven by the increased focus on improving automation, efficiency, and scalability to meet the growing commercial demand. Research and development make efforts to innovate new systems and components, like tubing that is used for cell processing and solvent suspension. ...
April 21, 2026
Projections indicate that, single-use sterile connectors for cell therapy industry is projected to rise from USD 1.30 billion in 2025 to USD 4.34 billion by 2035, reflecting a CAGR of 12.8% over the next decade. The growing demand for personalized medicines and new cell therapy launches bolsters market growth. The presence of key players and favora...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com